Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8769105 | Actas Urológicas Españolas | 2018 | 14 Pages |
Abstract
The incidence of positive RB in patients with non-muscle invasive bladder cancer was 21.91%. The maximum usefulness of RB was observed when these are performed in a standardized way. The results of the meta-analysis showed that besides positive cytology and non-papillary appearance tumors, tumor multiplicity and histological grades G2 and G3 represent risk factors associated to positive RB, suggesting that the use of RB might be extensive to the intermediate risk group of the European Organization for Research and Treatment of Cancer (EORTC).
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
J.D. Subiela, J. Palou, C. Esquinas, J.M. Fernández Gómez, O. RodrÃguez Faba,